Get startedLog in
    Picture of Theratechnologies logo

    TH — Theratechnologies News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapTurnaround
    All News

    Brief: Theratechnologies Announces First Patient Dosed In Phase 1 Clinical Trial Of TH1902

    Picture of Theratechnologies logoTheratechnologies
    24/03/2021 11:31
    March 24 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES ANNOUNCES FIRST PATIENT DOSED IN PHASE 1
CLINICAL TRIAL OF TH1902 FOR SORTILIN POSITIVE SOLID TUMORS

Source text for Eikon:  ID:nGNX6RQTng 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Theratechnologies

    See all news